Evidence map›Paper›PMID 31636108›Full record

ArticleJournal of bacteriology2020

Metallochaperones Are Needed for Mycobacterium tuberculosis and Escherichia coli Nicotinamidase-Pyrazinamidase Activity.

Patricia Sheen, Anuntxi Monsalve, Jhanina Campos, Rodolfo Huerta, Ricardo Antiparra, Héctor Arteaga, Patricia Duran, Carlos Bueno, Daniela E Kirwan, Robert H Gilman and 1 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of bacteriology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Patricia SheenLaboratory of Bioinformatics and Molecular Biology, Department of Cellular and Molecular Sciences, School of Science, Universidad Peruana Cayetano Heredia, Lima, Peru.
Anuntxi MonsalveLaboratory of Bioinformatics and Molecular Biology, Department of Cellular and Molecular Sciences, School of Science, Universidad Peruana Cayetano Heredia, Lima, Peru.
Jhanina CamposLaboratory of Bioinformatics and Molecular Biology, Department of Cellular and Molecular Sciences, School of Science, Universidad Peruana Cayetano Heredia, Lima, Peru.
Rodolfo HuertaLaboratory of Bioinformatics and Molecular Biology, Department of Cellular and Molecular Sciences, School of Science, Universidad Peruana Cayetano Heredia, Lima, Peru.
Ricardo AntiparraLaboratory of Bioinformatics and Molecular Biology, Department of Cellular and Molecular Sciences, School of Science, Universidad Peruana Cayetano Heredia, Lima, Peru.
Héctor ArteagaLaboratory of Bioinformatics and Molecular Biology, Department of Cellular and Molecular Sciences, School of Science, Universidad Peruana Cayetano Heredia, Lima, Peru.
Patricia DuranLaboratory of Bioinformatics and Molecular Biology, Department of Cellular and Molecular Sciences, School of Science, Universidad Peruana Cayetano Heredia, Lima, Peru.
Carlos BuenoLaboratory of Bioinformatics and Molecular Biology, Department of Cellular and Molecular Sciences, School of Science, Universidad Peruana Cayetano Heredia, Lima, Peru.
Daniela E KirwanInfection and Immunity Research Institute, St. George's, University of London, London, United Kingdom.
Robert H GilmanDepartment of International Health, School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.
Mirko ZimicLaboratory of Bioinformatics and Molecular Biology, Department of Cellular and Molecular Sciences, School of Science, Universidad Peruana Cayetano Heredia, Lima, Peru mirko.zimic@upch.pe.
Universidad Peruana Cayetano Heredia · PEJohns Hopkins University · USSt George's, University of London · GB

Funding

Changes in Oral and Gut Microbiota and Incidence and Severity of Patient-Reported Symptoms in Pre- and Post-Kidney Transplant PatientsK23NR018482 · NINR · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LOCKWOOD, MARK · 2019 to 2021
$486k
Medical Research Council MR/K007467/1Medical Research Council MR/P019978/1Medical Research Council MR/P019978/2NINR NIH HHS K23 NR018482Wellcome TrustWellcome Trust 099805/Z/12/Z
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antitubercular AgentsDrug Resistance, BacterialEscherichia coliMetallochaperonesMicrobial Sensitivity TestsMycobacterium tuberculosisNicotinamidasePyrazinamideAntitubercular AgentsMetallochaperonesNicotinamidasePyrazinamidepyrazinoic acidmechanism of actionmechanism of resistancemetal depletionmetallochaperonemetalloenzymeMycobacterium tuberculosispyrazinamidepyrazinoic acidPZA resistancereactivationresistanceRv2059ZnuA

Identifiers

PMID31636108
PMCPMC6941528
OpenAlexW2981730085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.